Expanded boxed warning on IV Iron

The FDA has released an expanded boxed warning on IV Iron dextran products, due to anaphylactic reactions. They are recommending a test dose be given to all patients before full dose injection, and that resuscitation equipment and personnel be available during the infusion (site). IV iron should be reserved for patients with iron deficiency anemia, who are unable to replete their iron stores orally.

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment